Exposure assessment in the hard metal manufacturing industry with special regard to tungsten and its compounds
T Krausa, P Schramelb, K H Schallera, P Zöbeleina, A Webera, J Angerera
a Institute and
Outpatient Clinic for Occupational, Social and Environmental Medicine
of the University of Erlangen-Nürnberg, Schillerstra
e 25 and 29, D-91054 Erlangen, Germany, b Institute for Ecological Chemistry, GSF
Neuherberg, Germany
Correspondence to: Dr T Kraus thomas.p.kraus{at}rzmail.uni-erlangen.de
Accepted 30 April 2001
OBJECTIVES
To assess
the exposure to tungsten, cobalt, and nickel in a plant producing hard
metals. The main components of hard metals are tungsten carbide and
cobalt metal. According to recent studies, these two components may be
responsible for both fibrogenic and carcinogenic effects.
METHODS
87 workers
were investigated (86 male, one female) with a median age of 42 (range
22-58) and a mean duration of exposure of 13 years (range 1-27
years). Stationary and personal air sampling, and biological monitoring
were carried out.
RESULTS
Ambient
monitoring yielded maximum tungsten concentrations of 417 µg/m3 in the production of heavy alloys. A maximum cobalt
concentration of 343 µg/m3 and a maximum nickel
concentration of 30 µg/m3 were found at the sintering
workshop. The highest urinary cobalt concentrations were found in the
powder processing department. The mean concentration was 28.5 µg/g
creatinine and the maximum value was 228 µg/g creatinine. The maximum
nickel concentration in urine of 6.3 µg/g creatinine was detected in
the department producing heavy alloys. The highest tungsten
concentrations excreted in urine were found in grinders and had a mean
value of 94.4 µg/g creatinine and a maximum of 169 µg/g
creatinine. Due to the different solubility and bioavailability of the
substance, there was no correlation between the tungsten concentrations
in air and urine on a group basis.
CONCLUSIONS
Despite
its low solubility, tungsten carbide is bioavailable. The different
bioavailability of tungsten metal and tungsten compounds has to be
considered in the interpretation of ambient and biological monitoring
data in the hard metal producing industry. The bioavailability
increases in the order: tungsten metal, tungsten carbide, tungstenate.
Only if both monitoring strategies are considered in combination can a
valid and effective definition of high risk groups be derived.
Keywords: tungsten; cobalt; biological monitoring
© 2001 by Occupational and Environmental Medicine
This article has been cited by other articles:
-
Colognato, R., Bonelli, A., Ponti, J., Farina, M., Bergamaschi, E., Sabbioni, E., Migliore, L.
(2008). Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitro. Mutagenesis
23: 377-382
[Abstract] [Full Text] -
Keith, L. S., Wohlers, D. W., Moffett, D. B., Rosemond, Z. A.
(2007). ATSDR evaluation of potential for human exposure to tungsten. Toxicol Ind Health
23: 309-345
[Abstract] -
GARDE, A. H., HANSEN, A. M., KRISTIANSEN, J., KNUDSEN, L. E.
(2004). Comparison of Uncertainties Related to Standardization of Urine Samples with Volume and Creatinine Concentration. ANN OCCUP HYG
48: 171-179
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
